General MedicationsNASALStandard
OMNARIS
CICLESONIDE
Standard Dose
0.05MG/SPRAY
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview OMNARIS is listed in Drugs@FDA under application 022004 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CICLESONIDE Form and strength SPRAY, METERED;NASAL - 0.05MG/SPRAY Sponsor AZURITY Submission history Latest submission status date: 2019-05-08 00:00:00.
Structured Monograph
Clinical summary
Approval overview OMNARIS is listed in Drugs@FDA under application 022004 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CICLESONIDE Form and strength SPRAY, METERED;NASAL - 0.05MG/SPRAY Sponsor AZURITY Submission history Latest submission status date: 2019-05-08 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.